JPWO2022130342A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022130342A5 JPWO2022130342A5 JP2023537572A JP2023537572A JPWO2022130342A5 JP WO2022130342 A5 JPWO2022130342 A5 JP WO2022130342A5 JP 2023537572 A JP2023537572 A JP 2023537572A JP 2023537572 A JP2023537572 A JP 2023537572A JP WO2022130342 A5 JPWO2022130342 A5 JP WO2022130342A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- heavy chain
- chain monomer
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025197132A JP2026041774A (ja) | 2020-12-18 | 2025-11-18 | 四価ＦＺＤ及びＷＮＴコレセプター（ｃｏ－ｒｅｃｅｐｔｏｒ）結合抗体分子並びにその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063127408P | 2020-12-18 | 2020-12-18 | |
| US63/127,408 | 2020-12-18 | ||
| PCT/IB2021/061972 WO2022130342A1 (en) | 2020-12-18 | 2021-12-17 | Tetravalent fzd and wnt co-receptor binding antibody molecules and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025197132A Division JP2026041774A (ja) | 2020-12-18 | 2025-11-18 | 四価ＦＺＤ及びＷＮＴコレセプター（ｃｏ－ｒｅｃｅｐｔｏｒ）結合抗体分子並びにその使用 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023554500A JP2023554500A (ja) | 2023-12-27 |
| JP2023554500A5 JP2023554500A5 (https=) | 2025-05-20 |
| JPWO2022130342A5 true JPWO2022130342A5 (https=) | 2025-05-20 |
| JP7778148B2 JP7778148B2 (ja) | 2025-12-01 |
Family
ID=82058983
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023537572A Active JP7778148B2 (ja) | 2020-12-18 | 2021-12-17 | 四価ＦＺＤ及びＷＮＴコレセプター（ｃｏ－ｒｅｃｅｐｔｏｒ）結合抗体分子並びにその使用 |
| JP2023537540A Pending JP2024500839A (ja) | 2020-12-18 | 2021-12-17 | 四価ＦＺＤ及びＷＮＴコレセプター（ｃｏ－ｒｅｃｅｐｔｏｒ）結合抗体分子並びにその使用 |
| JP2025197132A Pending JP2026041774A (ja) | 2020-12-18 | 2025-11-18 | 四価ＦＺＤ及びＷＮＴコレセプター（ｃｏ－ｒｅｃｅｐｔｏｒ）結合抗体分子並びにその使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023537540A Pending JP2024500839A (ja) | 2020-12-18 | 2021-12-17 | 四価ＦＺＤ及びＷＮＴコレセプター（ｃｏ－ｒｅｃｅｐｔｏｒ）結合抗体分子並びにその使用 |
| JP2025197132A Pending JP2026041774A (ja) | 2020-12-18 | 2025-11-18 | 四価ＦＺＤ及びＷＮＴコレセプター（ｃｏ－ｒｅｃｅｐｔｏｒ）結合抗体分子並びにその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US20250270332A1 (https=) |
| EP (3) | EP4263617A4 (https=) |
| JP (3) | JP7778148B2 (https=) |
| KR (1) | KR20230122077A (https=) |
| CN (2) | CN116917332A (https=) |
| AU (2) | AU2021399278A1 (https=) |
| CA (2) | CA3204321A1 (https=) |
| CL (2) | CL2023001768A1 (https=) |
| IL (2) | IL303344A (https=) |
| MX (1) | MX2023007103A (https=) |
| WO (2) | WO2022130342A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3732201A4 (en) | 2017-12-19 | 2022-04-20 | Surrozen Operating, Inc. | WNT SURROGATES AND THEIR USES |
| CN120025448A (zh) * | 2019-06-11 | 2025-05-23 | 安托拉诊疗公司 | 多价fzd和wnt结合分子及其用途 |
| WO2023250402A2 (en) * | 2022-06-22 | 2023-12-28 | Antlera Therapeutics Inc. | Tetravalent fzd and wnt co-receptor binding antibody molecules and uses thereof |
| WO2023130055A2 (en) * | 2021-12-31 | 2023-07-06 | Surrozen Operating, Inc. | Wnt receptor-specific compound and method relating thereto |
| WO2024007008A2 (en) * | 2022-06-30 | 2024-01-04 | The University Of Chicago | Cd73 (nt5e) targeting polypeptides |
| WO2024227103A1 (en) * | 2023-04-27 | 2024-10-31 | Surrozen Operating, Inc. | Molecules modulating wnt signaling pathways and uses thereof |
| WO2025019458A2 (en) * | 2023-07-14 | 2025-01-23 | The Trustees Of Columbia University In The City Of New York | Specific blood retinal barrier defect in glaucoma directs new treatments and clinical tests |
| WO2025168716A1 (en) | 2024-02-07 | 2025-08-14 | Eyebiotech Limited | Compositions, doses, and methods for treatment of ocular diseases |
| WO2025176847A1 (en) | 2024-02-21 | 2025-08-28 | Ags Therapeutics Sas | Ocular delivery of active agents via microalgae extracellular vesicles |
| US20260092125A1 (en) * | 2024-09-06 | 2026-04-02 | Eyebiotech Limited | Multivalent fzd4, wnt co-receptor, and vegf binding molecules and uses thereof |
| WO2026055312A1 (en) * | 2024-09-06 | 2026-03-12 | Merck Sharp & Dohme Llc | Multivalent fzd4, wnt co-receptor, and vegf receptor molecules and uses thereof |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2405246A1 (en) | 1990-12-03 | 1992-06-11 | Genentech, Inc. | Enrichment method for variant proteins with alterred binding properties |
| AU784983B2 (en) | 1999-12-15 | 2006-08-17 | Genentech Inc. | Shotgun scanning, a combinatorial method for mapping functional protein epitopes |
| EP1513879B1 (en) | 2002-06-03 | 2018-08-22 | Genentech, Inc. | Synthetic antibody phage libraries |
| CA2510003A1 (en) | 2003-01-16 | 2004-08-05 | Genentech, Inc. | Synthetic antibody phage libraries |
| US7785903B2 (en) | 2004-04-09 | 2010-08-31 | Genentech, Inc. | Variable domain library and uses |
| EP1957531B1 (en) | 2005-11-07 | 2016-04-13 | Genentech, Inc. | Binding polypeptides with diversified and consensus vh/vl hypervariable sequences |
| WO2007064919A2 (en) | 2005-12-02 | 2007-06-07 | Genentech, Inc. | Binding polypeptides with restricted diversity sequences |
| JP2009536527A (ja) | 2006-05-09 | 2009-10-15 | ジェネンテック・インコーポレーテッド | 最適化されたスキャフォールドを備えた結合ポリペプチド |
| CN100592373C (zh) | 2007-05-25 | 2010-02-24 | 群康科技(深圳)有限公司 | 液晶显示面板驱动装置及其驱动方法 |
| CN103002911B (zh) | 2008-09-26 | 2015-08-26 | 昂考梅德药品有限公司 | 卷曲蛋白结合药剂及其应用 |
| EP2804629A1 (en) | 2012-01-18 | 2014-11-26 | Genentech, Inc. | Anti-lrp5 antibodies and methods of use |
| DE102012202081A1 (de) | 2012-02-13 | 2013-08-14 | Osram Gmbh | Glühfaden für elektrische lampen und elektrische lampe sowie herstellungsverfahren für einen glühfaden |
| AU2014246658B2 (en) | 2013-04-03 | 2018-10-04 | Peter Maccallum Cancer Institute | Antibodies against human RYK and uses therefor |
| US9237411B2 (en) | 2013-07-25 | 2016-01-12 | Elwha Llc | Systems and methods for providing one or more functionalities to a wearable computing device with directional antenna |
| EP3033356B1 (en) | 2013-08-14 | 2020-01-15 | Sachdev Sidhu | Antibodies against frizzled proteins and methods of use thereof |
| JP6865688B2 (ja) | 2015-01-16 | 2021-04-28 | ジュノー セラピューティクス インコーポレイテッド | Ｒｏｒ１に特異的な抗体およびキメラ抗原受容体 |
| US10919968B2 (en) | 2016-01-29 | 2021-02-16 | Modmab Therapeutics Corporation | Frizzled5 protein-binding agents |
| WO2018026942A1 (en) | 2016-08-02 | 2018-02-08 | Merrimack Pharmaceuticals, Inc. | Heteromeric polypeptides |
| US11039659B2 (en) | 2017-09-07 | 2021-06-22 | Nike, Inc. | Sole structure for article of footwear |
| US20210032352A1 (en) | 2018-02-14 | 2021-02-04 | Antera Therapeutics Inc. | Multivalent Binding Molecules Activating WNT Signaling and Uses Thereof |
| CA3104526A1 (en) * | 2018-07-05 | 2020-01-09 | Surrozen, Inc. | Multi-specific wnt surrogate molecules and uses thereof |
| US10671121B2 (en) | 2018-09-14 | 2020-06-02 | Apple Inc. | Magnetic layout in electronic devices and accessory devices for electronic devices |
| CN120025448A (zh) * | 2019-06-11 | 2025-05-23 | 安托拉诊疗公司 | 多价fzd和wnt结合分子及其用途 |
-
2021
- 2021-12-17 WO PCT/IB2021/061972 patent/WO2022130342A1/en not_active Ceased
- 2021-12-17 MX MX2023007103A patent/MX2023007103A/es unknown
- 2021-12-17 AU AU2021399278A patent/AU2021399278A1/en active Pending
- 2021-12-17 CN CN202180093862.1A patent/CN116917332A/zh active Pending
- 2021-12-17 IL IL303344A patent/IL303344A/en unknown
- 2021-12-17 CA CA3204321A patent/CA3204321A1/en active Pending
- 2021-12-17 EP EP21905972.2A patent/EP4263617A4/en active Pending
- 2021-12-17 AU AU2021404080A patent/AU2021404080A1/en active Pending
- 2021-12-17 EP EP21905973.0A patent/EP4263618A4/en active Pending
- 2021-12-17 CA CA3204322A patent/CA3204322A1/en active Pending
- 2021-12-17 CN CN202180093864.0A patent/CN116964102A/zh active Pending
- 2021-12-17 US US18/267,914 patent/US20250270332A1/en active Pending
- 2021-12-17 IL IL303342A patent/IL303342A/en unknown
- 2021-12-17 KR KR1020237023863A patent/KR20230122077A/ko active Pending
- 2021-12-17 JP JP2023537572A patent/JP7778148B2/ja active Active
- 2021-12-17 JP JP2023537540A patent/JP2024500839A/ja active Pending
- 2021-12-17 WO PCT/IB2021/061971 patent/WO2022130341A1/en not_active Ceased
-
2022
- 2022-06-22 US US17/846,846 patent/US20230118983A1/en active Pending
-
2023
- 2023-06-15 CL CL2023001768A patent/CL2023001768A1/es unknown
- 2023-06-22 EP EP23741240.8A patent/EP4543921A2/en active Pending
- 2023-11-03 US US18/501,589 patent/US20240228631A9/en not_active Abandoned
-
2025
- 2025-05-20 CL CL2025001491A patent/CL2025001491A1/es unknown
- 2025-11-18 JP JP2025197132A patent/JP2026041774A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2022130342A4 (en) | Tetravalent fzd and wnt co-receptor binding antibody molecules and uses thereof | |
| US12398204B2 (en) | Method of treating an ocular condition by administering multispecific antibodies that activates TIE2 and binds a receptor tyrosine kinase agonist | |
| JP2020196744A5 (https=) | ||
| JP6742245B2 (ja) | 多重特異性抗体 | |
| TWI803876B (zh) | 具有交叉結合區定向之雙重可變區類抗體結合蛋白 | |
| JP2023085476A5 (https=) | ||
| JP2019533441A5 (https=) | ||
| JP2021533779A5 (https=) | ||
| JP2018537966A5 (https=) | ||
| IL292780A (en) | A new 4-1bbl trimer containing antigen-binding molecules | |
| JP2017537896A5 (https=) | ||
| JP2021507698A5 (https=) | ||
| JPWO2022130342A5 (https=) | ||
| JP7657591B2 (ja) | 二重特異性抗原結合コンストラクト | |
| JP2025160226A5 (https=) | ||
| JP2025124718A5 (https=) | ||
| JPWO2021076564A5 (https=) | ||
| JPWO2020037150A5 (https=) | ||
| JPWO2022102768A5 (https=) | ||
| JPWO2022042488A5 (https=) | ||
| JPWO2023045977A5 (https=) | ||
| JPWO2022241082A5 (https=) | ||
| JPWO2023056252A5 (https=) | ||
| JP2025527160A (ja) | 多重特異性抗体およびその使用 | |
| JPWO2021148006A5 (https=) |